4//SEC Filing
HSIA DAVID C 4
Accession 0001179110-04-016298
CIK 0000884629other
Filed
Aug 10, 8:00 PM ET
Accepted
Aug 11, 3:33 PM ET
Size
8.5 KB
Accession
0001179110-04-016298
Insider Transaction Report
Form 4
HSIA DAVID C
Sr. VP, Scientific Affairs
Transactions
- Award
Stock Options to Purchase Common Stock
2004-08-09+16,000→ 16,000 totalExercise: $26.14From: 2005-08-09Exp: 2014-08-09→ Common Stock, par value $0.0033 (16,000 underlying)
Holdings
- 579,064(indirect: By Trust)
Common Stock, par value $0.0033
- 1,024,218(indirect: By Partnership)
Common Stock, par value $0.0033
- 40,000(indirect: By Trust)
Common Stock, par value $0.0033
- 260,000
Common Stock, par value $0.0033
Footnotes (2)
- [F1]The options are to be incentive stock options to the extent permitted by law, and thereafter to be non-statutory stock options.
- [F2]These stock options become exercisable in five annual installments of 3,200 each commencing on August 9, 2005.
Documents
Issuer
WATSON PHARMACEUTICALS INC
CIK 0000884629
Entity typeother
Related Parties
1- filerCIK 0001258176
Filing Metadata
- Form type
- 4
- Filed
- Aug 10, 8:00 PM ET
- Accepted
- Aug 11, 3:33 PM ET
- Size
- 8.5 KB